Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Kirk

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Molecular Plant Pathology|April 21, 2015
Scab resistance in 'Geneva' apple is conditioned by a resistance gene cluster with complex genetic controlHéloïse Bastiaanse, Heather C M Bassett, Christopher Kirk, et al.
International Journal of Sports Physiology and Performance|December 6, 2022
Rapid Weight Gain and Weight Differential Predict Competitive Success in 2100 Professional Combat-Sport AthletesVincent Baribeau, Christopher Kirk, Danny Q Le, et al.
Journal of Medicinal Chemistry|November 2, 2018
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide)Henry W B Johnson, Eric Lowe, Janet L Anderl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2012
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomibZhengping Wang, Jinfu Yang, Christopher Kirk, et al.
Drug Testing and Analysis|August 7, 2025
Comment on "Biology and Management of Male-Bodied Athletes in Elite Female Sports" by Handelsman and BermonGregory A Brown, Brandon Shaw, Ina Shaw, et al.
Journal of the International Society of Sports Nutrition|August 28, 2025
Weight loss practices in Chinese national and international-level Sanda athletesYuming Zhong, Weiwei Tang, Thomas I Gee, et al.
ACS Medicinal Chemistry Letters|April 25, 2017
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) SubunitHenry W B Johnson, Janet L Anderl, Erin K Bradley, et al.
The Journal of Biological Chemistry|January 28, 2010
N-terminal domains of DELLA proteins are intrinsically unstructured in the absence of interaction with GID1/gibberellic acid receptorsXiaolin Sun, William T Jones, Dawn Harvey, et al.
British Journal of Haematology|February 25, 2015
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell deathYuko Mishima, Loredana Santo, Homare Eda, et al.
Journal of Human Evolution|July 27, 2016
Internal carotid arterial canal size and scaling in Euarchonta: Re-assessing implications for arterial patency and phylogenetic relationships in early fossil primatesDoug M Boyer, E Christopher Kirk, Mary T Silcox, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Molecular Plant Pathology|April 21, 2015
Scab resistance in 'Geneva' apple is conditioned by a resistance gene cluster with complex genetic controlHéloïse Bastiaanse, Heather C M Bassett, Christopher Kirk, et al.
International Journal of Sports Physiology and Performance|December 6, 2022
Rapid Weight Gain and Weight Differential Predict Competitive Success in 2100 Professional Combat-Sport AthletesVincent Baribeau, Christopher Kirk, Danny Q Le, et al.
Journal of Medicinal Chemistry|November 2, 2018
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide)Henry W B Johnson, Eric Lowe, Janet L Anderl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2012
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomibZhengping Wang, Jinfu Yang, Christopher Kirk, et al.
Drug Testing and Analysis|August 7, 2025
Comment on "Biology and Management of Male-Bodied Athletes in Elite Female Sports" by Handelsman and BermonGregory A Brown, Brandon Shaw, Ina Shaw, et al.
Journal of the International Society of Sports Nutrition|August 28, 2025
Weight loss practices in Chinese national and international-level Sanda athletesYuming Zhong, Weiwei Tang, Thomas I Gee, et al.
ACS Medicinal Chemistry Letters|April 25, 2017
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) SubunitHenry W B Johnson, Janet L Anderl, Erin K Bradley, et al.
The Journal of Biological Chemistry|January 28, 2010
N-terminal domains of DELLA proteins are intrinsically unstructured in the absence of interaction with GID1/gibberellic acid receptorsXiaolin Sun, William T Jones, Dawn Harvey, et al.
British Journal of Haematology|February 25, 2015
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell deathYuko Mishima, Loredana Santo, Homare Eda, et al.
Journal of Human Evolution|July 27, 2016
Internal carotid arterial canal size and scaling in Euarchonta: Re-assessing implications for arterial patency and phylogenetic relationships in early fossil primatesDoug M Boyer, E Christopher Kirk, Mary T Silcox, et al.
Pageof 8